SCHEMBL24945813

SCHEMBL24945813

CC(C)(C)c1c(O)ccc(Cl)c1C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 17/20 0.42
CYP3A4 P08684 1/20 0.37
MAPK1 P28482 1/20 0.37
TMPRSS4 Q9NRS4 1/20 0.34
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CHRNB2 P17787 1/20 0.33
CYP2B6 P20813 1/20 0.33
MAOA P21397 1/20 0.33
CYP2C19 P33261 1/20 0.33
CHRNA4 P43681 1/20 0.33
HTR3A P46098 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24069516 0.78 CYP3A4 (0.38) CYP3A4MAPK1ALDH1A1HPGDALOX15
SCHEMBL23226961 0.78 NOTUM (0.44) NOTUMCYP3A4MAPK1TMPRSS4CYP1A2
SCHEMBL70068 0.78 ALDH1A1 (0.48) CYP3A4MAPK1ALDH1A1HPGDALOX15
SCHEMBL30027143 0.78 ALDH1A1 (0.48) CYP3A4MAPK1ALDH1A1HPGDALOX15
SCHEMBL27963029 0.78 ALDH1A1 (0.48) CYP3A4MAPK1ALDH1A1HPGDALOX15
SCHEMBL24806431 0.77 CYP3A4 (0.52) CYP3A4MAPK1ALDH1A1HPGDALOX15
SCHEMBL6230443 0.77 CYP3A4 (0.41) CYP3A4MAPK1ALDH1A1HPGDALOX15
SCHEMBL24946313 0.76 CSNK2A2 (0.38) NOTUMCYP3A4MAPK1TMPRSS4ALDH1A1
SCHEMBL12804773 0.75 NOTUM (0.41) NOTUMCYP3A4MAPK1TMPRSS4ALDH1A1
SCHEMBL3218264 0.75 CYP3A4 (0.39) CYP3A4MAPK1ALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230131535-A1 ARYLMETHYLENE AROMATIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC 2023-04-27 US disclosed
US-20230131535-A1 ARYLMETHYLENE AROMATIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC 2023-04-27 US disclosed
US-20230026611-A1 ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026611-A1 ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS KCNA3, KCNH2, KCNJ2 NOTUM 3513/4885CYP3A4 373/4885MAPK1 530/4885
US-20230131535-A1 ARYLMETHYLENE AROMATIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS KCNJ2, KCNA3, KCNK3 NOTUM 3381/4885CYP3A4 465/4885MAPK1 492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.